Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases.
To contact Derek email him directly: derekb.lowe@gmail.com
Twitter: Dereklowe
Here's a Reuters headline for you: "GSK rejects idea of buying AstraZeneca".
In other news, Delta Airlines has rejected the idea of making its new fleet of long-range passenger jets out of bamboo and stale Fig Newton bars. There are also reports this morning that Burger King has rejected the idea of buying Birkenstock and cramming their sandals into buns in lieu of hamburger patties. More business news as it become available.
2. Ricardo Rodriges on May 4, 2012 6:40 AM writes...
Now, american airlines buying AZ, that would be a headline I would like to read, couldn't mismanage much more the company ... well, better not to give them a challenge :-D
A related story, but I'm sure it's one you're following: "With his recent (failed) attempt at humor, noted bloggist Dr. Lowe has rejected the idea of becoming a humor columnist."
Sure the idea seems fanciful these days, but not more than 3 years ago it would have seemed perfectly rational - at least to business journalists, merger lawyers and CEOs.
In other news, the Huffington Post has ruled out buying In The Pipeline. “Getting involved with real facts would be too much of a distraction,” said Huffer-in-chief Arianna Huffington.
A truly damning verdict on AZ. My thoughts and best wishes go out to all its employees left watching as Brennan slinks off with suitcases stuffed with cash. I heard he cut 31,000 during his reign - to achieve what precisely?
Well, GSK bought Sirtris... Doh!! I wouldn't be surprised if they actually buy AZ in the end. After all, management lies and tries to hide their real intentions. We are in for some serious "consolidation" in big pharma in the next 1-2 yrs. Watch out AZ, you have no future. In the end I see Pfizer, GSK and Novartis as the players in big pharma. The others will be consumed....and their bones (employees) will fall victim. Beware my friends...take shelter...
1. PPedroso on May 4, 2012 6:33 AM writes...
Well,
I also reject the idea of buying AstraZeneca.
:)
Permalink to Comment2. Ricardo Rodriges on May 4, 2012 6:40 AM writes...
Now, american airlines buying AZ, that would be a headline I would like to read, couldn't mismanage much more the company ... well, better not to give them a challenge :-D
Permalink to Comment3. Nick K on May 4, 2012 6:46 AM writes...
Thank you Derek, made my day!
Permalink to Comment4. schinderhannes on May 4, 2012 6:54 AM writes...
With Burger King, the customers wouldn´t notice the difference!
Permalink to Comment5. CR on May 4, 2012 7:30 AM writes...
A related story, but I'm sure it's one you're following: "With his recent (failed) attempt at humor, noted bloggist Dr. Lowe has rejected the idea of becoming a humor columnist."
Permalink to Comment6. partial agonist on May 4, 2012 8:04 AM writes...
Derek,
Any thoughts on the Nature paper on pyroglutamylated (or pyroglu) beta-amyloid as the "real bad guy" in Alzheimer’s disease?
Permalink to Comment7. johnnyboy on May 4, 2012 8:42 AM writes...
Sure the idea seems fanciful these days, but not more than 3 years ago it would have seemed perfectly rational - at least to business journalists, merger lawyers and CEOs.
Permalink to Comment8. Anonymous on May 4, 2012 10:27 AM writes...
Derek, they're just called Newtons now -- not Fig Newtons. Or did you miss today's today's other big headline: http://newsfeed.time.com/2012/05/03/name-change-fig-newtons-are-now-just-newtons/
Permalink to Comment9. Paul on May 4, 2012 2:15 PM writes...
So #8, if I make an impulse purchase of more cookies, the correct unit of measurement would be newton-seconds?
Permalink to Comment10. Joel on May 4, 2012 3:43 PM writes...
In other news, the Huffington Post has ruled out buying In The Pipeline. “Getting involved with real facts would be too much of a distraction,” said Huffer-in-chief Arianna Huffington.
Permalink to Comment11. Fred on May 5, 2012 7:40 AM writes...
News Flash: GSK demonstrates good judgment for once.
Permalink to Comment12. Vim on May 5, 2012 2:03 PM writes...
A truly damning verdict on AZ. My thoughts and best wishes go out to all its employees left watching as Brennan slinks off with suitcases stuffed with cash. I heard he cut 31,000 during his reign - to achieve what precisely?
Permalink to Comment13. Sweden Calling on May 5, 2012 3:37 PM writes...
We (as in AZ) are not interested in buying GSK either. ; )
Permalink to Comment14. Anonymous on May 5, 2012 7:02 PM writes...
Well, GSK bought Sirtris... Doh!! I wouldn't be surprised if they actually buy AZ in the end. After all, management lies and tries to hide their real intentions. We are in for some serious "consolidation" in big pharma in the next 1-2 yrs. Watch out AZ, you have no future. In the end I see Pfizer, GSK and Novartis as the players in big pharma. The others will be consumed....and their bones (employees) will fall victim. Beware my friends...take shelter...
Permalink to Comment15. anonymous on May 6, 2012 5:30 PM writes...
@14
Permalink to CommentDo you really see Merck as gone???? I think NOT!
16. pandora on May 6, 2012 9:00 PM writes...
mind you that GSK was answering a question brought up
Permalink to Commentby someone.
17. Vim on May 7, 2012 5:47 AM writes...
Keep an eye out for the 5 words that have foreshadowed the end of many a country's industrial base: "creation of a national champion".
Permalink to Comment18. timmy on May 7, 2012 9:52 AM writes...
tt-t-TIMMAY!
Permalink to Comment